rs1131691092
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001042492.3(NF1):c.3525_3526delAA(p.Arg1176SerfsTer18) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000137 in 1,461,880 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001042492.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NF1 | NM_001042492.3 | c.3525_3526delAA | p.Arg1176SerfsTer18 | frameshift_variant | Exon 27 of 58 | ENST00000358273.9 | NP_001035957.1 | |
NF1 | NM_000267.3 | c.3525_3526delAA | p.Arg1176SerfsTer18 | frameshift_variant | Exon 27 of 57 | NP_000258.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461880Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 727244
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neurofibromatosis, type 1 Pathogenic:6
- -
- -
This sequence change creates a premature translational stop signal (p.Arg1176Serfs*18) in the NF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with neurofibromatosis type 1 (PMID: 10712197, 17914445, 18546366, 22155606, 26969325). This variant is also known as c.3525delAA. ClinVar contains an entry for this variant (Variation ID: 428971). For these reasons, this variant has been classified as Pathogenic. -
_x000D_ Criteria applied: PVS1, PS4_MOD, PM2_SUP -
The variant is not observed in the gnomAD v2.1.1 dataset. Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000428971 / PMID: 10712197). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
not provided Pathogenic:3
- -
- -
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Also known as 3525delAA; This variant is associated with the following publications: (PMID: 18546366, 21031597, 18041031, 22155606, 31776437, 26969325, 16941471, 16138229, 30308447, 10712197) -
Neurofibromatosis, type 1;C0349639:Juvenile myelomonocytic leukemia;C0553586:Café-au-lait macules with pulmonary stenosis;C1834235:Neurofibromatosis, familial spinal;C2931482:Neurofibromatosis-Noonan syndrome Pathogenic:1
PVS1+PM2_Supporting+PS4_Supporting+PP4+PM6 -
Hereditary cancer-predisposing syndrome Pathogenic:1
Thec.3525_3526delAApathogenic mutation, located in codingexon27 of theNF1gene, results from a deletion of two nucleotides at nucleotide positions 3525 and 3526, causing a translationalframeshiftwith a predicted alternate stopcodon. This mutation has been detected in multiple individuals who meet NIH clinical criteria for NF1(FahsoldR, et al. Am. J. Hum. Genet. 2000;66(3):790-818;Trovó-MarquiAB, et al.Braz. J. Med.Biol. Res. 2005;38(9):1441-7;BrinckmannA, et al. Electrophoresis 2007;28(23):4295-301).In addition to the clinical data presented in the literature, sinceframeshiftsare typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMGRecommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at